dsm-firmenich sees 1% sales decline in Beauty & Care for H1 FY25
This performance is primarily due to weak end-user demand and customer destocking of sun filters.
SWITZERLAND – dsm-firmenich has announced a 1% decline in sales in its Beauty & Care segment in the first half of 2025, reporting €1.989 billion(USD 2.17 billion), down from €2.007 billion (USD 2.19 billion) in the previous year.
According to the company, this performance is primarily due to weak end-user demand and customer destocking of sun filters.
dsm-firmenich reported a strong financial performance for the first half of 2025, with revenue reaching €6.51 billion (USD 7.10 billion), a 3.4% increase compared to the prior year, supported by 7% organic sales growth amid favourable business conditions and some macroeconomic uncertainties.
Adjusted EBITDA rose 29% to €1.26 billio(USD 1.37 billion), pushing the adjusted EBITDA margin up by 390 basis points to 19.4%, reflecting improved profitability driven by the vitamin transformation program, collaborations, divestments, and favourable FX effects.
Core adjusted net profit increased by 47% to €537 million(USD 585.8 million), with core earnings per share rising 42% to €1.92(USD 2.22).
Dimitri de Vreeze, CEO at dsm-firmenich, stated, “We are pleased to report a good performance in the first six months, with good organic sales and earnings growth and the effective execution of our strategic plan.”
“Through our combined capabilities, we continue to make good progress in delivering comprehensive cost and revenue collaboration across our businesses, demonstrating the success of our merger.”
Other than the beauty and care sector, the Taste, Texture & Health segment showed outstanding performance with 6% organic sales growth and an increased adjusted EBITDA margin to 20.1%.
Animal Nutrition & Health also delivered strong sales growth of 18%, supported by price increases and the vitamin price effect, significantly boosting adjusted EBITDA and margin.
Looking ahead, the group anticipates a full-year Adjusted EBITDA of approximately €2.4 billion(USD 2.82 billion) for 2025, factoring in volatile foreign exchange rate impacts.
This forecast incorporates an expected €150 million (USD 171.3 million) contribution from a temporary vitamin price effect, around €125 million (USD 142.6 million) of which was already recorded in the first half of the year.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
